STEX just had a pretty big insider buy, with the company’s Chief Investment Officer picking up about $285K worth of shares around $3 on Jan 26.
What makes it interesting is the company recently did a pretty wild pivot, rebranding from BioSig into Streamex and shifting toward tokenizing things like gold and other real-world assets on blockchain.
Kind of a weird transition for a microcap, so I’m curious if insiders think this new direction is starting to click, or if the market just overreacted to the uncertainty around the pivot and dilution.